Cumulative effects of raloxifene on the incidence of breast cancer over 8 years in postmenopausal women with osteoporosis.

被引：0
|
作者：
Mershon, J.
Yea, A.
Qu, Y.
Wong, M.
Mitchell, B.
Vogel, V.
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] Univ Pittsburgh, Pittsburgh, PA USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2007年 / 106卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S180 / S180
页数：1
相关论文
共 50 条
  • [41] Managing the risk of invasive breast cancer in women at risk for breast cancer and osteoporosis: the role of raloxifene
    Vogel, Victor G.
    CLINICAL INTERVENTIONS IN AGING, 2008, 3 (04): : 601 - 609
  • [42] Effects of teriparatide on serum calcium in postmenopausal women with osteoporosis previously treated with raloxifene or alendronate
    R. A. Wermers
    C. P. Recknor
    F. Cosman
    L. Xie
    E. V. Glass
    J. H. Krege
    Osteoporosis International, 2008, 19 : 1055 - 1065
  • [43] Effects of raloxifene on fracture severity in postmenopausal women with osteoporosis: Results from the MORE study
    Siris, E
    Adachi, JD
    Lu, Y
    Fuerst, T
    Crans, GG
    Wong, M
    Harper, KD
    Genant, HK
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 (11) : 907 - 913
  • [44] Early effects of raloxifene on clinical vertebral fractures at 12 months in postmenopausal women with osteoporosis
    Maricic, M
    Adachi, JD
    Sarkar, S
    Wu, WT
    Wong, M
    Harper, KD
    ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (10) : 1140 - 1143
  • [45] Effects of teriparatide on serum calcium in postmenopausal women with osteoporosis previously treated with raloxifene or alendronate
    Wermers, R. A.
    Recknor, C. P.
    Cosman, F.
    Xie, L.
    Glass, E. V.
    Krege, J. H.
    OSTEOPOROSIS INTERNATIONAL, 2008, 19 (07) : 1055 - 1065
  • [46] Comparison of preventive effects of bisphosphonate and raloxifene on glucocorticoid-induced osteoporosis in postmenopausal women
    Takayanagi, Ryoichi
    Ohnaka, Keizo
    Kawate, Hisaya
    Adachi, Masahiro
    Nomura, Masatoshi
    ENDOCRINE JOURNAL, 2010, 57 : S488 - S489
  • [47] The effects of teriparatide on the incidence of back pain in postmenopausal women with osteoporosis
    Genant, HK
    Halse, J
    Briney, WG
    Xie, L
    Glass, EV
    Krege, JH
    CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (07) : 1027 - 1034
  • [48] Effects of raloxifene on markers of cardiovascular risk in non-Caucasian postmenopausal women with osteoporosis
    Johnson, S
    Kulkarni, P
    Qu, Y
    Ciaccia, A
    Keech, C
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2003, 10 (06): : 567 - 567
  • [49] Effects of Raloxifene on Fracture Severity in Postmenopausal Women with Osteoporosis: Results from the MORE Study
    E. Siris
    J. D. Adachi
    Y. Lu
    T. Fuerst
    G. G. Crans
    M. Wong
    K. D. Harper
    H. K. Genant
    Osteoporosis International, 2002, 13 : 907 - 913
  • [50] Responder Analysis of the Effects of Abaloparatide and Teriparatide on Bone Mineral Density in Postmenopausal Women With Osteoporosis.
    Leder, Benjamin
    Banks, Kathleen
    O'Dea, Louis
    Lyttle, C. R.
    Yates, John
    Hattersley, Gary
    JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 : S111 - S111
12345